✦ LIBER ✦

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

✍ Scribed by Michael McClung; Robert Recker; Paul Miller; Darrell Fiske; Jerome Minkoff; Audrey Kriegman; Wenchun Zhou; Mathews Adera; Jenny Davis

Book ID: 116320014
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 189 KB
Volume: 41
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2007.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A single zoledronic acid infusion reduce

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density

✍ Kenneth Saag; Robert Lindsay; Audrey Kriegman; Emily Beamer; Wenchun Zhou 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Sonja Gamsjaeger; Birgit Buchinger; Ruth Zoehrer; Roger Phipps; Klaus Klaushofer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Effects of Yearly Zoledronic Acid 5 mg o

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

✍ Pierre D Delmas; Francoise Munoz; Dennis M Black; Felicia Cosman; Steven Boonen; 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 653 KB

Relationship of changes in total hip bon

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

✍ Richard M Jacques; Steven Boonen; Felicia Cosman; Ian R Reid; Douglas C Bauer; D 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on iliac bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women treated prior with alendronate or risedronate

✍ B.M. Misof; E.P. Paschalis; R. Zoehrer; S. Blouin; N. Fratzl-Zelman; R. Phipps; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB